Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Beta-glucuronidase inhibitors as antitumor/antiinflammatory agents

Oct. 26, 1998

Potent antitumor activity, low toxicity observed in in vitro studies of aplidine

Oct. 23, 1998

Cell Therapeutics initiates phase I lisofylline trial for treatment of mucositis

Oct. 22, 1998

ODAC votes against Warner-Lambert's prostate cancer drug

Oct. 20, 1998

Paclitaxel derivatives useful as antitumor agents prepared at BMS

Oct. 20, 1998

DepoTech withdraws MAA for Savedar for solid tumor indication

Oct. 19, 1998

Melatonin prevents doxorubicin-induced cardiotoxicity in rat model

Oct. 19, 1998

New drug delivery technology soon to enter clinical testing

Oct. 19, 1998

Wayne Hughes Institute develops potent new agent for breast cancer

Oct. 16, 1998

Gene for Rx, Dx of liver cancer available for licensing from RCT

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...